DegreeMD, Rush Medical College, 1990; MBA, Tuck School of Business, 1972; AB, College of the Holy Cross, 1970
AREAS OF EXPERTISEHealth care business strategy
Business development in licensing and strategic alliances for U.S. and global markets in health care
Academic positions: Tuck School of Business, 2004–present; Co-Director, MD/MBA Program at Dartmouth, 2004–present; Adjunct Associate Professor, Department of Community and Family Medicine, Geisel School of Medicine, 1996–present
Nonacademic positions: Consultant to pharmaceutical and biotechnology industries, 2004; Head of Global Health Economics and Outcomes Research, Aventis Pharma Inc., 2000–04; Director, Epidemiology and Outcomes Research, Abbott Laboratories, 1994–99; Associate Medical Director, G.D. Searle and Co., 1992; Senior Scientist, Division of Health Care Technology, 1990, Associate Director, Department of Technology Management, 1990–92, American Medical Association; General Partner, Van Buren Investment Co., 1985–87; Market Maker, CBOE Member, R.M.D. Trading Co., 1984–85; Account Executive, BBDO International, 1977–79; Product Manager, Avon Products, Inc., 1975–77; Product Manager, New Products, Pfizer Labs, Pfizer, Inc., 1972–75
Board memberships: Executive Board, Patient Advocates Foundation
Donald Conway offers unique perspective as physician and business executive, having previously worked in both research and business development for the American Medical Association and major pharmaceutical companies. His current focus is on strategic alliances in global health care markets. Professor Conway teaches the Business in Health Care elective.